Peters, Solange

Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS trial

Peters, S., Felip, E., Dafni, U., Belka, C., Guckenberger, M., Irigoyen, A., Nadal, E., Becker, A., Vees, H., Pless, M., et al. (2019) · Lung Cancer

Lung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers

Cited by 162

Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: Comparative pharmacokinetics and drug–drug interactions

Peters, S., Zimmermann, S., & Adjei, A. A. (2014) · Cancer Treatment Reviews

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research

Cited by 155

Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases

Zimmermann, S., Dziadziuszko, R., & Peters, S. (2014) · Cancer Treatment Reviews

Brain Metastases and TreatmentLung Cancer Treatments and Mutations

Cited by 147

Prevalence and Clinical Outcomes for Patients With ALK Gene Rearrangement in Europe: Preliminary Results from the European Thoracic Oncology Platform Lungscape Project

Blackhall, F., Peters, S., Kerr, K. M., O'Byrne, K., Hager, H., Sejda, A., Soltermann, A., Dooms, C., Felip, E., Marchetti, A., et al. (2012) · Annals of Oncology

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 21